Archive

Strategy, appointments, major clinical, medical and regulatory advances, and partnerships: you can find all the latest Ipsen Group press releases here.

BYLVAY® SAG
BYLVAY® AVB
IPN60250 (A3907) CSP
IPN60260 (A2342) CV
ELAFIBRANOR CSP
FIDRISERTIB FOP
ELAFIBRANOR 2L CBP
PALOVAROTENE FOP
IPN60130 FOP
© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023